|
US3709898A
(en)
|
1971-02-09 |
1973-01-09 |
Upjohn Co |
Process for the production of triazolobenzodiazepines and intermediates
|
|
US3681343A
(en)
|
1971-05-11 |
1972-08-01 |
Upjohn Co |
6-phenyl-s-triazolo{8 4,3-a{9 {8 1,4{9 {0 benzodiazepines
|
|
US3812259A
(en)
|
1971-08-09 |
1974-05-21 |
Upjohn Co |
Animal feed and process
|
|
CH622019A5
(en)
|
1975-10-23 |
1981-03-13 |
Upjohn Co |
Process for the preparation of aminotriazolobenzodiazepines
|
|
FR2329668A1
(fr)
|
1975-10-27 |
1977-05-27 |
Upjohn Co |
Procede de preparation d'aminotriazolobenzodiazepines
|
|
US4210644A
(en)
|
1978-02-23 |
1980-07-01 |
The Johns Hopkins University |
Male contraception
|
|
US4379454A
(en)
|
1981-02-17 |
1983-04-12 |
Alza Corporation |
Dosage for coadministering drug and percutaneous absorption enhancer
|
|
EP0087850A1
(en)
|
1982-01-04 |
1983-09-07 |
The Upjohn Company |
Benzodiazepines for anti-hypertensive use
|
|
DE3435973A1
(de)
*
|
1984-10-01 |
1986-04-10 |
Boehringer Ingelheim KG, 6507 Ingelheim |
Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
|
|
US4743249A
(en)
|
1986-02-14 |
1988-05-10 |
Ciba-Geigy Corp. |
Dermal and transdermal patches having a discontinuous pattern adhesive layer
|
|
DE3724164A1
(de)
|
1986-07-25 |
1988-01-28 |
Boehringer Ingelheim Kg |
Neue 1,4-benzodiazepine, ihre herstellung und verwendung
|
|
US4906169A
(en)
|
1986-12-29 |
1990-03-06 |
Rutgers, The State University Of New Jersey |
Transdermal estrogen/progestin dosage unit, system and process
|
|
US5023084A
(en)
|
1986-12-29 |
1991-06-11 |
Rutgers, The State University Of New Jersey |
Transdermal estrogen/progestin dosage unit, system and process
|
|
DE3878833T2
(de)
*
|
1987-05-28 |
1993-06-09 |
Yoshitomi Pharmaceutical |
Thieno(triazolo)diazepinverbindungen, und medizinische verwendung derselben.
|
|
US4816540A
(en)
|
1987-06-12 |
1989-03-28 |
Yasuhiko Onishi |
Cationic graft-copolymer
|
|
US5422119A
(en)
|
1987-09-24 |
1995-06-06 |
Jencap Research Ltd. |
Transdermal hormone replacement therapy
|
|
US5035891A
(en)
|
1987-10-05 |
1991-07-30 |
Syntex (U.S.A.) Inc. |
Controlled release subcutaneous implant
|
|
JPH0676326B2
(ja)
|
1988-05-24 |
1994-09-28 |
吉富製薬株式会社 |
循環器系疾患治療薬
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
EP0368175A1
(de)
|
1988-11-06 |
1990-05-16 |
Boehringer Ingelheim Kg |
3S,7S-3-(Morpholinocarbonyl)-5-(2-chlorphenyl)-7,10-dimethyl-3,4-dihydro-2H,7H-cyclopenta[4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin.
|
|
EP0387613A1
(de)
|
1989-03-03 |
1990-09-19 |
Boehringer Ingelheim Kg |
Neue Thienodiazepine
|
|
US4973468A
(en)
|
1989-03-22 |
1990-11-27 |
Cygnus Research Corporation |
Skin permeation enhancer compositions
|
|
CA2020806A1
(en)
|
1989-07-12 |
1991-01-13 |
Karl-Heinz Weber |
Thienodiazepine derivatives
|
|
DE4010528A1
(de)
|
1990-04-02 |
1991-10-17 |
Boehringer Ingelheim Kg |
Praeparativ chromatographisches trennverfahren zur herstellung enantiomerenreiner hetrazepine
|
|
US5198223A
(en)
|
1990-10-29 |
1993-03-30 |
Alza Corporation |
Transdermal formulations, methods and devices
|
|
JP3239364B2
(ja)
|
1991-10-11 |
2001-12-17 |
ウェルファイド株式会社 |
骨粗鬆症治療薬およびジアゼピン化合物
|
|
WO1994006802A1
(fr)
*
|
1992-09-18 |
1994-03-31 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Compose de thienodiazepine et son utilisation medicinale
|
|
WO1994022872A1
(fr)
|
1993-03-30 |
1994-10-13 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Inhibiteur d'adhesion cellulaire et compose a base de thienotriazolodiazepine
|
|
WO1995032963A1
(en)
|
1994-06-01 |
1995-12-07 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Thienylazole compound and thienotriazolodiazepine compound
|
|
CN1168140A
(zh)
*
|
1995-01-06 |
1997-12-17 |
弗·哈夫曼-拉罗切有限公司 |
羟甲基咪唑并二氮杂䓬及其酯
|
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
|
CN1101680C
(zh)
*
|
1995-09-09 |
2003-02-19 |
弗·哈夫曼-拉罗切有限公司 |
噻吩并三唑并二氮杂䓬增加载脂蛋白a－1含量的用途
|
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
|
PL330635A1
(en)
|
1996-06-12 |
1999-05-24 |
Japan Tobacco Inc |
Inhibitor of cytokin production, triazepin compound and intermediate compounds used for obtaining the last mentioned one
|
|
US5693641A
(en)
|
1996-08-16 |
1997-12-02 |
Berlex Laboratories Inc. |
Bicyclic pyrimidine derivatives and their use as anti-coagulants
|
|
WO1998011111A1
(en)
|
1996-09-13 |
1998-03-19 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Thienotriazolodiazepine compounds and medicinal uses thereof
|
|
US6444664B1
(en)
|
1997-04-18 |
2002-09-03 |
Nederlandse Organisatie Voor Toegepast - Natuurweten Schappelijk Onderzoek (Tno) |
Method for controlling the plasma level of lipoproteins to treat alzheimeris disease
|
|
JPH11228576A
(ja)
|
1997-12-10 |
1999-08-24 |
Japan Tobacco Inc |
アポトーシス抑制剤
|
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
|
FR2779652B1
(fr)
|
1998-06-15 |
2001-06-08 |
Sod Conseils Rech Applic |
Utilisation de diazepines pour la preparation de medicaments destines a traiter les etats pathologiques ou les maladies dans lesquels un des recepteurs de la somatostatine est implique
|
|
US7589167B2
(en)
|
2000-02-22 |
2009-09-15 |
J. David Gladstone Institutes |
ZA loops of bromodomains
|
|
JP4875277B2
(ja)
|
2000-06-16 |
2012-02-15 |
田辺三菱製薬株式会社 |
放出ｐＨ域及び／又は速度制御組成物
|
|
US6552037B2
(en)
|
2000-06-30 |
2003-04-22 |
Neurogen Corporation |
2-Substituted imidazo[1,2-A]pyridine derivatives
|
|
US20060142257A1
(en)
|
2001-01-19 |
2006-06-29 |
Eberhard Nieschlag |
Male contraceptive formulation comprising norethisterone
|
|
US6979682B2
(en)
|
2001-02-23 |
2005-12-27 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Platelet-activating factor antagonist inhibition of angiogenesis and tumor growth induced by basic fibroblast
|
|
US20030216758A1
(en)
|
2001-12-28 |
2003-11-20 |
Angiotech Pharmaceuticals, Inc. |
Coated surgical patches
|
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
|
US6861422B2
(en)
|
2003-02-26 |
2005-03-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
|
WO2005002526A2
(en)
|
2003-07-01 |
2005-01-13 |
President And Fellows Of Harvard College |
Method and compositions for treatment of viral infections
|
|
AU2004272288B2
(en)
|
2003-09-18 |
2008-11-13 |
Novartis Ag |
2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
|
|
EP1528056A1
(en)
|
2003-10-29 |
2005-05-04 |
Academisch Ziekenhuis bij de Universiteit van Amsterdam |
Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
|
|
US20060035903A1
(en)
|
2004-08-14 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Storage stable perfusion solution for dihydropteridinones
|
|
US7759485B2
(en)
|
2004-08-14 |
2010-07-20 |
Boehringer Ingelheim International Gmbh |
Process for the manufacture of dihydropteridinones
|
|
US20060074088A1
(en)
|
2004-08-14 |
2006-04-06 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones for the treatment of cancer diseases
|
|
US20060058311A1
(en)
|
2004-08-14 |
2006-03-16 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation
|
|
CN1759834B
(zh)
|
2004-09-17 |
2010-06-23 |
中国医学科学院医药生物技术研究所 |
黄连素或其与辛伐他汀联合在制备用于预防或治疗与血脂有关疾病或症状的产品中用途
|
|
WO2006129623A1
(ja)
*
|
2005-05-30 |
2006-12-07 |
Mitsubishi Tanabe Pharma Corporation |
チエノトリアゾロジアゼピン化合物及びその医薬としての用途
|
|
WO2007014838A1
(en)
|
2005-08-03 |
2007-02-08 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones in the treatment of respiratory diseases
|
|
WO2007053452A1
(en)
|
2005-11-01 |
2007-05-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
US8604042B2
(en)
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
US8133900B2
(en)
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
|
WO2007076348A2
(en)
|
2005-12-23 |
2007-07-05 |
Smithkline Beecham Corporation |
Azaindole inhibitors of aurora kinases
|
|
KR101062583B1
(ko)
|
2006-01-17 |
2011-09-06 |
에프. 호프만-라 로슈 아게 |
Ｇａｂａ 수용체에 의해 알츠하이머병의 치료에 유용한아릴-아이속사졸-4-일-이미다조[1,2-ａ]피리딘
|
|
ATE479434T1
(de)
|
2006-02-14 |
2010-09-15 |
Vertex Pharma |
Als protein-kinase-inhibitoren nutzbare dyhydrodiazepine
|
|
US20070218135A1
(en)
|
2006-03-14 |
2007-09-20 |
Glenmark Pharmaceuticals Limited |
Sustained release matrix pharmaceutical composition
|
|
DE602007008553D1
(de)
|
2006-05-03 |
2010-09-30 |
Novartis Ag |
Verwendung von organischen verbindungen
|
|
ES2627352T3
(es)
|
2006-10-19 |
2017-07-27 |
Signal Pharmaceuticals, Llc |
Compuestos heteroarilo, sus composiciones y su uso como inhibidores de proteínas quinasas
|
|
WO2008066887A2
(en)
|
2006-11-30 |
2008-06-05 |
Albert Einstein College Of Medicine Of Yeshiva University |
Small molecule inhibitors of bcl6
|
|
DK2474523T3
(da)
|
2006-12-26 |
2020-07-13 |
Lantheus Medical Imaging Inc |
Ligander til billeddannelse af hjerte-innervation
|
|
WO2008137081A1
(en)
|
2007-05-02 |
2008-11-13 |
The Trustees Of Columbia University In The City Of New York |
Substituted ( 5, 6 ) -dihydronaphraalenyl compounds as reversible male contraceptives
|
|
KR20080107050A
(ko)
|
2007-06-05 |
2008-12-10 |
울산대학교 산학협력단 |
항-ｃｄ１３７ 단일클론 항체를 포함하는 만성이식편대숙주 질환의 예방 또는 치료용 약학적 조성물
|
|
US7935964B2
(en)
|
2007-06-19 |
2011-05-03 |
Samsung Electronics Co., Ltd. |
Oxide semiconductors and thin film transistors comprising the same
|
|
CA2710118A1
(en)
|
2007-12-20 |
2009-07-02 |
Cellzome Limited |
Sulfamides as zap-70 inhibitors
|
|
CN101910182B
(zh)
|
2007-12-28 |
2013-07-17 |
田边三菱制药株式会社 |
抗癌剂
|
|
US20110098288A1
(en)
|
2008-03-11 |
2011-04-28 |
Jeremy Major |
Sulfonamides as zap-70 inhibitors
|
|
WO2010015340A1
(en)
|
2008-08-06 |
2010-02-11 |
Bayer Schering Pharma Aktiengesellschaft |
Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment
|
|
CN102292341B
(zh)
*
|
2008-10-30 |
2014-09-10 |
环行医学有限责任公司 |
对apo a有活性的噻吩并三唑并二氮杂*衍生物
|
|
EP2379559B1
(en)
|
2009-01-06 |
2017-10-25 |
Dana-Farber Cancer Institute, Inc. |
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
|
|
EP2389379A1
(en)
|
2009-01-23 |
2011-11-30 |
Takeda Pharmaceutical Company Limited |
Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
|
|
GB0919431D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919426D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
AU2010317096B2
(en)
|
2009-11-05 |
2015-03-26 |
Glaxosmithkline Llc |
Benzodiazepine bromodomain inhibitor
|
|
GB0919423D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
CA2779355C
(en)
|
2009-11-05 |
2018-01-16 |
Glaxosmithkline Llc |
Benzodiazepine bromodomain inhibitor
|
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
US20120329803A1
(en)
|
2010-02-17 |
2012-12-27 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones, method for production and use thereof
|
|
WO2011143651A1
(en)
|
2010-05-14 |
2011-11-17 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating metabolism
|
|
CN103154246B
(zh)
|
2010-05-14 |
2015-11-25 |
达那-法伯癌症研究所 |
用于治疗白血病的组合物和方法
|
|
CN103180318B
(zh)
|
2010-05-14 |
2017-05-10 |
达那-法伯癌症研究所 |
雄性避孕组合物以及使用方法
|
|
ES2606958T3
(es)
|
2010-05-14 |
2017-03-28 |
Dana-Farber Cancer Institute, Inc. |
Compuestos de tienotriazolodiazepina para tratar una neoplasia
|
|
EP2585465B1
(en)
|
2010-06-22 |
2014-11-12 |
GlaxoSmithKline LLC |
Benzotriazolodiazepine compounds inhibitors of bromodomains
|
|
US20120014979A1
(en)
|
2010-07-16 |
2012-01-19 |
Alexander Dent |
Use of bcl6 inhibitors for treating autoimmune diseases
|
|
WO2012075456A1
(en)
|
2010-12-02 |
2012-06-07 |
Constellation Pharmaceuticals |
Bromodomain inhibitors and uses thereof
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
EP2677865A4
(en)
|
2011-02-23 |
2015-04-22 |
Icahn School Med Mount Sinai |
BROMODOMAIN INHIBITORS AS MODULATORS OF GENE EXPRESSION
|
|
WO2012118812A2
(en)
|
2011-02-28 |
2012-09-07 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
|
WO2013033269A1
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bioorthogonal monomers capable of dimerizing and targeting bromodomains and methods of using same
|
|
WO2013033268A2
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bivalent bromodomain ligands, and methods of using same
|
|
WO2013097052A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Laboratories |
Bromodomain inhibitors
|
|
WO2013123521A1
(en)
|
2012-02-17 |
2013-08-22 |
Nexbio, Inc. |
Methods, Compounds and Compositions for Treatment of Parainfluenza Virus in Immunocompromised Patients
|
|
US20150133434A1
(en)
|
2012-03-28 |
2015-05-14 |
The J. David Gladstone Institutes |
Compositions and Methods for Reactivating Latent Immunodeficiency Virus
|
|
WO2014071247A1
(en)
|
2012-11-02 |
2014-05-08 |
Dana-Farber Cancer Institute, Inc. |
Pyrrol-1 -yl benzoic acid derivates useful as myc inhibitors
|
|
WO2014159392A1
(en)
|
2013-03-14 |
2014-10-02 |
Dana-Farber Cancer Institute, Inc. |
Bromodomain binding reagents and uses thereof
|
|
BR112016001457A2
(pt)
|
2013-07-25 |
2017-08-29 |
Dana Farber Cancer Inst Inc |
Inibidores de fatores de transcrição e usos dos mesmos
|
|
AU2014323526B2
(en)
|
2013-09-19 |
2020-07-23 |
Dana-Farber Cancer Institute, Inc. |
Methods of BH3 profiling
|
|
WO2015081284A1
(en)
|
2013-11-26 |
2015-06-04 |
Coferon, Inc. |
Bivalent bromodomain ligands, and methods of using same
|
|
WO2015117083A1
(en)
|
2014-01-31 |
2015-08-06 |
Dana-Farber Cancer Institute, Inc. |
Diazepane derivatives and uses thereof
|
|
EP3099693A4
(en)
|
2014-01-31 |
2017-08-16 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
|
MX2016009974A
(es)
|
2014-01-31 |
2016-10-31 |
Dana Farber Cancer Inst Inc |
Derivados de diaminopirimidina bencensulfona y sus usos.
|